Worldwide sales were $6.1 billion in the second quarter of 2008, a decrease of 1% from the second quarter of 2007. For the first six months of 2008, worldwide sales were $11.9 billion and net income was $5.07 billion.
Richard Clark, chairman, president and CEO of Merck, said: “For the second quarter, Merck made good progress launching innovative new pharmaceutical and vaccine products around the world and driving efficiencies in many parts of the business. Although some results didn’t meet our expectations, we are taking action to address our challenges, and remain committed to regaining leadership in the pharmaceutical industry.”